[go: up one dir, main page]

WO2008122425A3 - Oral compositions containing tacrolimus in amorphous form - Google Patents

Oral compositions containing tacrolimus in amorphous form Download PDF

Info

Publication number
WO2008122425A3
WO2008122425A3 PCT/EP2008/002716 EP2008002716W WO2008122425A3 WO 2008122425 A3 WO2008122425 A3 WO 2008122425A3 EP 2008002716 W EP2008002716 W EP 2008002716W WO 2008122425 A3 WO2008122425 A3 WO 2008122425A3
Authority
WO
WIPO (PCT)
Prior art keywords
amorphous form
active principle
compositions containing
agent
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/002716
Other languages
French (fr)
Other versions
WO2008122425A2 (en
Inventor
Celestino Ronchi
Giancarlo Ceschel
Luca Rampoldi
Manuela Astulfoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monteresearch Srl
Original Assignee
Monteresearch Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monteresearch Srl filed Critical Monteresearch Srl
Publication of WO2008122425A2 publication Critical patent/WO2008122425A2/en
Publication of WO2008122425A3 publication Critical patent/WO2008122425A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Fast release or modified release oral compositions containing as the active principle Tacrolimus and/or derivatives thereof in amorphous form, and: a) a 'solubilising agent' of the active principle suitable to maintain it in the amorphous form over time, b) at least one 'diluting agent' having the function to stabilize the active principle in the amorphous form, c) at least one agent being 'modulator' of the dissolution rate of the active principle from the pharmaceutical form. These compositions in form of paste, granules, powder, solution, suspension can be formulated in hard or soft gelatine capsules or can be formulated in other pharmaceutical forms for oral use. These compositions are characterized in that all the relative operations of preparation are carried out in the absence of water and/or organic solvents.
PCT/EP2008/002716 2007-04-06 2008-04-04 Oral compositions containing tacrolimus in amorphous form Ceased WO2008122425A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20070720 ITMI20070720A1 (en) 2007-04-06 2007-04-06 ORAL COMPOSITIONS CONTAINING TACROLIMUS IN AMORPHOUS FORM
ITMI2007A000720 2007-04-06

Publications (2)

Publication Number Publication Date
WO2008122425A2 WO2008122425A2 (en) 2008-10-16
WO2008122425A3 true WO2008122425A3 (en) 2009-01-08

Family

ID=39534833

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/002716 Ceased WO2008122425A2 (en) 2007-04-06 2008-04-04 Oral compositions containing tacrolimus in amorphous form

Country Status (2)

Country Link
IT (1) ITMI20070720A1 (en)
WO (1) WO2008122425A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102706357B1 (en) * 2015-08-19 2024-09-11 비버스 인크. Pharmaceutical preparations
CN113577032A (en) * 2021-08-27 2021-11-02 国药集团川抗制药有限公司 Preparation method of tacrolimus solid dispersion, quick-release pharmaceutical composition and application

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064942A1 (en) * 1998-03-26 2001-01-03 Fujisawa Pharmaceutical Co., Ltd. Sustained release preparations
EP1092429A1 (en) * 1993-07-08 2001-04-18 Novartis AG Pharmaceutical preparations for drugs of low solubility
WO2005020994A1 (en) * 2003-08-29 2005-03-10 Lifecycle Pharma A/S Solid dispersions comprising tacrolimus
WO2006062334A1 (en) * 2004-12-06 2006-06-15 Hanmi Pharm. Co., Ltd. Oral micro-emulsion composition comprising tacrolimus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1092429A1 (en) * 1993-07-08 2001-04-18 Novartis AG Pharmaceutical preparations for drugs of low solubility
EP1064942A1 (en) * 1998-03-26 2001-01-03 Fujisawa Pharmaceutical Co., Ltd. Sustained release preparations
WO2005020994A1 (en) * 2003-08-29 2005-03-10 Lifecycle Pharma A/S Solid dispersions comprising tacrolimus
WO2006062334A1 (en) * 2004-12-06 2006-06-15 Hanmi Pharm. Co., Ltd. Oral micro-emulsion composition comprising tacrolimus

Also Published As

Publication number Publication date
ITMI20070720A1 (en) 2008-10-07
WO2008122425A2 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
FR24C1014I1 (en) BENZONITRILE DERIVATIVES SUBSTITUTED WITH GLUCOPYRANOSYL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE AND PREPARATION OF SUCH COMPOUNDS
WO2007085833A3 (en) Pyrimidine derivatives
AU2003270255A1 (en) Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve
WO2008063910A3 (en) Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
UA96449C2 (en) Stable laquinimod preparations
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
IL189375A (en) 1-heterocyclylsulfonyl-3-aminomethyl, 5-(hetero)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
EP2252274A1 (en) Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
WO2007123955A3 (en) Stable hydroalcoholic oral spray formulations and methods
WO2007143652A3 (en) Chewable soft gelatin capsules
MX2010004222A (en) Solid formulations of crystalline compounds.
UA100866C2 (en) Solid dispersion product comprising n-aryl urea-based compounds
WO2006099121A3 (en) Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
MX2010003923A (en) Pharmaceutical formulation of valsartan.
PH12015501877A1 (en) Suspension for oral administration comprising amorphous tolvaptan
SI2046292T1 (en) Formulations for benzimidazolyl pyridyl ethers
TW200716202A (en) Pediatric formulation of topiramate
WO2012168885A9 (en) Bisacodyl and its analogues as drugs for use in the treatment of cancer
WO2008003050A3 (en) Gallium nitrate formulations
WO2009060952A1 (en) Novel preparation
WO2012020301A3 (en) Oral controlled release pharmaceutical compositions of blonanserin
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
WO2007016388A3 (en) Liquid formulations for controlled delivery of benzisoxazole derivatives
WO2013019091A3 (en) A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08735038

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08735038

Country of ref document: EP

Kind code of ref document: A2